(Q43899637)

English

Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival.

scientific article published in March 2002

Statements

Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival. (English)
Orion M Howard
John G Gribben
Donna S Neuberg
Christina Poor
Milos J Janicek
Margaret A Shipp
1 March 2002
1288-1294

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit